Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of aromatic anilides. It features a pyrazole core substituted with both difluoro and fluorinated phenyl groups. The molecule has been referenced in structural biology databases and chemical repositories but does not have an assigned CAS number or UNII. It is primarily studied as a research tool rather than as an approved pharmaceutical agent. Structural data suggest it may interact with serine/threonine-protein kinases involved in cell cycle regulation (notably CDK7), but there are no reports of clinical development or therapeutic use[1][2][3][4]. Its primary application appears to be preclinical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on {[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide.